Date Title Symbol Company Name Link
2022-06-01T12:49:26.000Z Certification of Interim Filings - CFO XPHYF XPhyto Therapeutics Corporation Link
2022-06-01T12:48:19.000Z Certification of Interim Filings - CEO XPHYF XPhyto Therapeutics Corporation Link
2022-06-01T12:45:16.000Z Management's Discussion and Analysis for the First Quarter Ended March 31, 2022 XPHYF XPhyto Therapeutics Corporation Link
2022-06-01T12:43:47.000Z Interim Financial Statements for the First Quarter Ended March 31, 2022 XPHYF XPhyto Therapeutics Corporation Link
2022-06-01T12:19:37.000Z CryptoStar Corp. Q1 2022 MDA May 30 2022 CSTXF Cryptostar Corp. Link
2022-06-01T12:19:05.000Z CryptoStar Corp. Q1 2022 FS May 30 2022 CSTXF Cryptostar Corp. Link
2022-06-01T12:14:48.000Z Q1 2022 Financial Statements SZLSF Stagezero Life Sciences Ltd. Link
2022-06-01T12:13:50.000Z Q1 2022 MD&A SZLSF Stagezero Life Sciences Ltd. Link
2022-06-01T11:19:21.000Z Three Months Ended March 31, 2022 KNBIF Kane Biotech Inc. Link
2022-06-01T11:18:00.000Z Three Months Ended March 31, 2022 KNBIF Kane Biotech Inc. Link

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

XPhyto Therapeutics Corp. published this content on 01 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 June 2022 13:01:04 UTC.